Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH)
Reviva Pharmaceuticals Holdings, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders. Founded to leverage its expertise in drug discovery and development, Reviva aims to address unmet medical needs through innovative solutions. The company's pipeline includes candidates targeting conditions such as depression, anxiety, and other neuropsychiatric disorders.
Company News
Reviva Pharmaceuticals announced a public offering of 27 million shares and accompanying warrants, raising approximately $9 million to fund research and development activities and working capital.
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) shares are surging after the company released topline results of its pivotal Phase 3 RECOVER trial evaluating brilaroxazine, a serotonin-dopamine signaling modulator in adults with schizophrenia. The trial met its primary endpoint, with brilaroxazine at the 50 mg dose achieving a statistically significant and clinically meaningful 10.1-point reduction in Positive and Negative Syndrome Scale (PANSS) total score compared to placebo (-23.9 brilaroxazine 50 mg vs. -13.8 placebo) at week 4. Roth Capital Partners writes that the data is robust across multiple endpoints, including ...Full story available on Benzinga.com
Penny stocks with bullish analyst ratings. Time to buy or avoid entirely? The post 4 Penny Stocks To Buy According To Analysts Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.